Home › Borstkanker › North Carolina › Durham
Borstkanker klinische studies in Durham, NC
64 studies voor Borstkanker zoeken deelnemers op locaties in en rond Durham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
A Study of PHST001 in Advanced Solid Tumors
RekruterenFase 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
RekruterenFase 2Gezonde vrijwilligers welkom
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruterenFase 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
RekruterenObservatieonderzoek
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
RekruterenFase 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- University of North Carolina Medical Center, Chapel Hill · 10 mijl verwijderd
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruterenFase 2
- University of North Carolina Medical Center, Chapel Hill · 10 mijl verwijderd
Identifying Patterns in the Breath of Individuals With Breast Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
RekruterenFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
RekruterenFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RekruterenObservatieonderzoek
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekruterenFase 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RekruterenFase 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RekruterenFase 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mijl verwijderd
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
RekruterenGezonde vrijwilligers welkom
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Rekruteren
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
RekruterenObservatieonderzoek
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Weight Management After Cancer for Survivors in Rural Communities
Rekruteren
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Rekruteren
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruterenFase 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Rekruteren
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RekruterenFase 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Rekruteren
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
RekruterenFase 1
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Rekruteren
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mijl verwijderd
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Rekruteren
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
RekruterenObservatieonderzoek
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekruterenFase 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
RekruterenFase 1
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
RekruterenFase 2Gezonde vrijwilligers welkom
- The University of North Carolina, Chapel Hill · 10 mijl verwijderd
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
RekruterenObservatieonderzoek
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Rekruteren
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
RekruterenFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mijl verwijderd
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruterenFase 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
RekruterenFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Rekruteren
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekruterenFase 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
RekruterenObservatieonderzoek
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
RekruterenFase 2
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Rekruteren
- UNC Cancer Hospital, Chapel Hill · 10 mijl verwijderd
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Rekruteren
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Rekruteren
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Rekruteren
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
BREAST Choice Decision Tool R21 - AIM2
RekruterenGezonde vrijwilligers welkom
- The University of North Carolina, Chapel Hill · 10 mijl verwijderd
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Rekruteren
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mijl verwijderd
UNC Pleural Fluid Registry
RekruterenObservatieonderzoek
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
- Arlington, VA47 studies
Andere studies in Durham
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker39 studies
- Multipel myeloom37 studies
- Acute myeloïde leukemie33 studies
- Metastatische kanker33 studies
- Prostaatkanker32 studies
- Longkanker32 studies
- Colorectale kanker28 studies
- Eierstokkanker27 studies
- Chronische lymfatische leukemie27 studies
- Hartfalen26 studies
- Aldermeesklierkanker24 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.